Supporting progress & translation of gene & cell therapies
The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.
Annual Conference
Annual Conference 2027, Join us in London 17th June.

Introducing the Current and New Members of the BSGCT Board
We are delighted to introduce the current and newly appointed members of the BSGCT Board. We are grateful to our existing Board members for their continued commitment and warmly welcome the new members joining us as we work together to advance the field of gene and cell therapy.


The British Society for Gene and Cell Therapy (BSGCT) serves as a collaborative platform to advance Gene and Cell Therapy (GCT) in the UK.
We proactively foster cooperation among stakeholders, including the public, patients, scientists, companies, government, and media to support the optimal development of GCT technologies and therapies.
Our charity is managed by volunteer members via an Elected-Board and Sub-Committees. We rely on the crucial support of our sponsors and members and invite you to get involved.
BSGCT News and Opportunities
ECR Seminar A Career Journey: from PhD to CEO
Join Dr Zoe Hewitt as she shares the story of her career journey, from completing her PhD to becoming Co-Founder…
BSGCT Annual Conference – Save The Date – 17 June 2027
Save the date to Join Us for the British Society for Gene and Cell Therapy’s Annual Conference Date: 17 June 2027…
Researcher Spotlight – Jyoti Yadav
Biography: Jyoti holds a Master’s degree with research experience in genetic engineering, DNA recombination, Heterologous cloning and sequencing, including laboratory…






